The Bivalirudin Drug Market in the US is also supported by continued investments in cardiovascular care, pharmaceutical research, and advanced treatment infrastructure.  Market Overview The global Bivalirudin Drug market was valued at US$ 1.58 billion in 2025 and is expected to reach US$ 2.72 billion by 2034; it is estimated to record a CAGR of 6.22% during 2026-2034.The market is being...